206. 脆弱Ｘ症候群 Fragile X syndrome Clinical trials / Disease details

臨床試験数 : 108 / 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04823052 (ClinicalTrials.gov)	May 25, 2022	24/3/2021	Investigation of Sulindac (HLX-0201) and Gaboxadol(HLX-0206) in Male Fragile X Syndrome Patients Age ...	A Phase 2, Placebo-controlled, Adaptive Design Study to Explore the Safety and Efficacy of Sulindac ...	Fragile X Syndrome	Drug: Sulindac (HLX-0201), dose strength 1;Drug: Sulindac (HLX-0201), dose strength 2;Drug: Placebo;Dr ...	Healx Limited	NULL	Withdrawn	13 Years	40 Years	Male	0	Phase 2	United States;Australia
2	NCT03697161 (ClinicalTrials.gov)	September 17, 2018	1/10/2018	A Study of OV101 in Individuals With Fragile X Syndrome	A Phase 2, Randomized, Double-Blind, Parallel-Group Study Evaluating the Safety, Tolerability, and E ...	Fragile X Syndrome (FXS)	Drug: OV101 (gaboxadol)	Ovid Therapeutics Inc.	NULL	Completed	13 Years	22 Years	Male	23	Phase 2	United States

First Previous1Next Last